Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
The U.S. government's principal agency for cancer research
Text messaging and mailing people free, at-home test kits can help boost the number of people who get screened for colorectal cancer.
The test could help patients with ER-positive breast cancer avoid months of ineffective treatment during which their disease may progress.
Efforts to reach patients during the COVID-19 pandemic has led to both setbacks and new innovations in cancer screening.
The new study showed that results for Black women on the breast cancer test Oncotype DX may be inaccurate.
In this Q&A, Dr. Pergam discusses some of the questions people with cancer and cancer survivors have about COVID-19 vaccines.
Obesity may render T cells around tumors less powerful by causing them to alter how they generate and use energy, a new study suggests.
The National Cancer Institute discusses the progress of the Cancer Moonshot to accelerate cancer research.
Study finds that using steroids to treat brain tumor symptoms may limit the effectiveness of immunotherapy drugs against these tumors.
Researchers have evidence that cholesterol-lowering drugs might offer a way to improve success rates of immunotherapy.
The nanoparticles led to more cancer-killing immune cells and slowed the growth of melanoma in mice.
People who received this form of radiation therapy for spinal metastases were pain-free up to 6 months after treatment.
The study found that people who live in counties in the United States that experience persistent poverty are more likely to die from cancer
Obesity, physical inactivity and smoking may be factors that are responsible for the rise of early-onset disease.
“Today, it is not only youth who are at risk for smoking initiation. We will need to carefully consider young adults as well.”
Researchers are developing a new class of drugs called radiopharmaceuticals, which deliver radiation therapy directly to cancer cells.
Keytruda plus chemotherapy should be a new standard of care as first-line therapy in patients with esophageal cancer, say researchers.
“Even though the tests have been around for a while, we don’t know how useful they’re really going to be in the clinical setting."
Researchers want to determine whether oligometastatic tumors can either prolong or improve the quality of life for patients.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.